Literature DB >> 7543098

Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine.

T Trüb1, W E Choi, G Wolf, E Ottinger, Y Chen, M Weiss, S E Shoelson.   

Abstract

Shc phosphorylation in cells following growth factor, insulin, cytokine, and lymphocyte receptor activation leads to its association with Grb2 and activation of Ras. In addition to being a cytoplasmic substrate of tyrosine kinases, Shc contains an SH2 domain and a non-SH2 phosphotyrosine binding (PTB) domain. Here we show that the Shc PTB domain, but not the SH2 domain, binds with high affinity (ID50 approximately equal to 1 microM) to phosphopeptides corresponding to the sequence surrounding Tyr250 of the polyoma virus middle T (mT) antigen (LLSNPTpYSVMRSK). Truncation studies show that five residues amino-terminal to tyrosine are required for high affinity binding, whereas all residues carboxyl-terminal to tyrosine can be deleted without loss of affinity. Substitution studies show that tyrosine phosphorylation is required and residues at -5, -3, -2, and -1 positions relative to pTyr are important for this interaction. 1H NMR studies demonstrate that the phosphorylated mT antigen-derived sequence forms a stable beta turn in solution, and correlations between structure and function indicate that the beta turn is important for PTB domain recognition. These results show that PTB domains are functionally distinct from SH2 domains. Whereas SH2 domain binding specificity derives from peptide sequences carboxyl-terminal to phosphotyrosine, the Shc PTB domain gains specificity by interacting with beta turn-forming sequences amino-terminal to phosphotyrosine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543098     DOI: 10.1074/jbc.270.31.18205

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling.

Authors:  David A Calderwood; Yosuke Fujioka; Jose M de Pereda; Begoña García-Alvarez; Tetsuya Nakamoto; Ben Margolis; C Jane McGlade; Robert C Liddington; Mark H Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-26       Impact factor: 11.205

2.  Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc.

Authors:  R Bronson; C Dawe; J Carroll; T Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivo.

Authors:  K S Ravichandran; M M Zhou; J C Pratt; J E Harlan; S F Walk; S W Fesik; S J Burakoff
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Sequence-specific recognition of the internalization motif of the Alzheimer's amyloid precursor protein by the X11 PTB domain.

Authors:  Z Zhang; C H Lee; V Mandiyan; J P Borg; B Margolis; J Schlessinger; J Kuriyan
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

5.  TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA.

Authors:  Matt K Lee; Cécile Pardoux; Marie C Hall; Pierre S Lee; David Warburton; Jing Qing; Susan M Smith; Rik Derynck
Journal:  EMBO J       Date:  2007-08-02       Impact factor: 11.598

6.  Kinase activation through dimerization by human SH2-B.

Authors:  Masahiro Nishi; Eric D Werner; Byung-Chul Oh; J Daniel Frantz; Sirano Dhe-Paganon; Lone Hansen; Jongsoon Lee; Steven E Shoelson
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

7.  The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase.

Authors:  J E Damen; L Liu; P Rosten; R K Humphries; A B Jefferson; P W Majerus; G Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

Review 8.  Phosphorylation of myelin protein: recent advances.

Authors:  J Eichberg; S Iyer
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

9.  Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.

Authors:  S Giorgetti-Peraldi; E Ottinger; G Wolf; B Ye; T R Burke; S E Shoelson
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

10.  Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling.

Authors:  K S Ravichandran; V Igras; S E Shoelson; S W Fesik; S J Burakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.